Neuromodulation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

The Neuromodulation Devices pipeline market research report provides comprehensive information about the Neuromodulation Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Neuromodulation Devices Pipeline Products Market Segmentation, by Territories

Some of the key territories with products in the pipeline are the US, Europe, South Korea, the UK, Australia China, Israel, Canada, Japan, and New Zealand. As of September 2022, the US has the highest number of products in the pipeline out of them all.

Neuromodulation Devices Pipeline Products Market Analysis, by Territories, 2022 (%)

Neuromodulation Devices Pipeline Products Market Analysis, by Territories

For more territory insights into the Neuromodulation devices pipeline products market, download a free report sample

Neuromodulation Devices Pipeline Products Market by Segments

The key segments in the Neuromodulation Devices pipeline products market are Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS), Peripheral Nerve Stimulators (PNS), Cortical Stimulators, Gastric Electric Stimulators (GES), Sacral Nerve Stimulators (SNS), and Leads. Deep Brain Stimulators have the greatest number of products in the pipeline.

 Neuromodulation Devices Pipeline Products Market Analysis, by Segments, 2022 (%)

Neuromodulation Devices Pipeline Products Market Analysis, by Segments

For more segment insights into the Neuromodulation devices pipeline products market, download a free report sample

Neuromodulation Devices Pipeline Products Market Segmentation by Key Regulatory Paths

Some of the key regulatory paths followed by the Neuromodulation Devices pipeline products market are PMA, 510(k), CE, TGA, de novo, UKCA, MDITAC, NMPA, HDE Approvals, and MDL. Most of the products follow the PMA pathway to enter the market.

Neuromodulation Devices Pipeline Products Market Analysis, by Regulatory Paths, 2022 (%)

Neuromodulation Devices Pipeline Products Market Analysis, by Regulatory Paths

For more Neuromodulation devices pipeline products regulatory path insights, download a free report sample

Competitive Landscape

Some of the leading companies in the Neuromodulation Devices pipeline products market are Aalto University, ab medica spa, Actegy Ltd., Actipulse Neuroscience Inc, Actuated Medical Inc, Adaptive Neuromodulation GmbH, Adept Neuro SA, Adriakaim Inc, Afferent Corporation, and Afferent Technologies.

Aalto University: It is an educational university that offers master’s degrees, doctoral degrees, graduate, postgraduate, and other programs. The university offers technology transfer and licensing to deploy its patented technologies in practice and carries out a wide variety of joint activities with companies and other partners. It offers services to students from Finland and other countries. Aalto University is headquartered in Espoo, Greater Helsinki, Finland.

AB Medica SpA: It is a medical technology company that offers robotic solutions. AB Medica offers services such as consultancy, assistance and training, surgical console, assembly and testing of medical devices, and others. The company partners with universities, research centers, and scientific laboratories. It has operations in Rome, Padova, and Fisciano. AB Medica is headquartered in Milan, Italy.

Actuated Medical Inc: It is a medical device company that develops minimally invasive instruments. The company provides products such as controlled tissue penetration systems, occlusion clearing systems, and MRI-compatible systems. It operates through a manufacturing facility in Bellefonte. Actuated Medical is headquartered in Bellefonte, Pennsylvania, the US.

Neuromodulation Devices Pipeline Products Market Report Overview

Key Territories The US, Europe, South Korea, the UK, Australia China, Israel, Canada, Japan, and New Zealand
Key Segments Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS), Peripheral Nerve Stimulators (PNS), Cortical Stimulators, Gastric Electric Stimulators (GES), Sacral Nerve Stimulators (SNS), and Leads
Key Regulatory Paths PMA, 510(k), CE, TGA, de novo, UKCA, MDITAC, NMPA, HDE Approvals, and MDL
Leading Companies Aalto University, ab medica spa, Actegy Ltd., Actipulse Neuroscience Inc, Actuated Medical Inc, Adaptive Neuromodulation GmbH, Adept Neuro SA, Adriakaim Inc, Afferent Corporation, and Afferent Technologies

Segments Covered in the Report

Neuromodulation Devices Pipeline Products Market Territories Outlook

  • The US
  • Europe
  • South Korea
  • the UK
  • Australia China
  • Israel
  • Canada
  • Japan
  • New Zealand

Neuromodulation Devices Pipeline Products Market Segments Outlook

  • Deep Brain Stimulators (DBS)
  • Spinal Cord Stimulators (SCS)
  • Vagus Nerve Stimulators (VNS)
  • Peripheral Nerve Stimulators (PNS)
  • Cortical Stimulators
  • Gastric Electric Stimulators (GES)
  • Sacral Nerve Stimulators (SNS)
  • Leads

Scope

This report provides:

  • Extensive coverage of the Neuromodulation Devices under development.
  • Details of major pipeline products which include product description, licensing, collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.
  • Reviews of the major players involved in the development of Neuromodulation Devices and lists all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from early development to the approved/issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent Developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Neuromodulation Devices under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Aalto University
ab medica spa
Actegy Ltd.
Actipulse Neuroscience Inc
Actuated Medical Inc
Adaptive Neuromodulation GmbH
Adept Neuro SA
Adriakaim Inc
Afferent Corporation
Afferent Technologies
Aleva Neurotherapeutics SA
Alfa Rhythm Ltd
Allegheny Health Network
Allevion Therapeutics Inc
Apnex Medical Inc
Attune Neurosciences Inc
Aucta Technologies Inc
AURIMOD GmbH
Avation Medical
Axilum Robotics
Axonic SAS
Axonics Inc
Barinetics Corporation
Battelle Memorial Institute
Baylor College of Medicine
BBB Technologies Inc
Beijing Lingchuang Yigu Technology Development Co Ltd
Beta-Stim LTD
BioElectric Solutions Inc.
Bioinduction Limited
Bioness Inc
Biophysical Mind Technologies Ltd.
Biospark Technologies Pte Ltd
Biotronik AG
Biotronik Inc
Biotronik SE & Co KG
BlueWind Medical Ltd
Boston Children's Hospital
Boston Scientific Corp
BrainsGate Ltd
Brainsway Ltd
Brazos Biomedical LLC
Brown University
Cadence Neuroscience Inc
Cala Health Inc
Callitas Therapeutics Inc
Cardionomic Inc
Carnegie Mellon University
Catalan Institute of Nanoscience and Nanotechnology
Cefaly Technology sprl
Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine
CerboMed GmbH
Cerebain Biotech Corp
Cerephex Corporation
Cerevast Therapeutics Inc
Charco Neurotech Ltd
Checkpoint Surgical Inc
Chordate Medical AB
Cibiem, Inc.
Cirtec Medical Corp
ClearPoint Medical
ClearPoint Neuro Inc
Cleveland Clinic
Cleveland Medical Devices Inc
Clinatec
CNX Medical Inc
Cognito Therapeutics Inc
Coloplast A/S
Columbia Engineering
Columbia University
Comphya SA
Conservocare, LLC
Coridea, LLC
Cortec GmbH
Cortivis
Cyberonics Inc
Deep Brain Innovations, LLC
Deep Brain Stimulation Technologies Pty Ltd
DEYMED Diagnostic
Dignify Therapeutics LLC
Direct Spinal Therapeutics, Inc.
Drexel University
Duke University
DuoCure Ltd.
Dysphagia
EBS Technologies GmbH
EBT Medical Inc
Ecole Polytechnique Federale de Lausanne
Eisana Corp
ElectroCore Inc
Elira Therapeutics Inc
EMKinetics, Inc.
Emory University School of Medicine
Endonovo Therapeutics Inc
EndoStim Inc
Enlight Medical Technologies (Shanghai) Co Ltd
Enopace Biomedical Ltd
Enspire DBS Therapy Inc
EPIC Neuro Inc
Epineuron Technologies Inc
EstimME Ltd.
Evonik Corp
Evren Technologies Inc
Exsurgo Ltd
Feelmore Labs Inc
FemPulse LLC
Fisher Wallace Laboratories, LLC
Flint Rehabilitation
Florida International University
Flow Neuroscience AB
FRD Accel LLC
Functional Neuromodulation Inc.
Futurecure Health Pvt Ltd
G6 Technologies Corporation
Galvani Bioelectronics Ltd
Georgia Institute of Technology
Ghoonuts Co Ltd
GiMer Medical
Gondola Medical Technologies SA
GrayMatters Health Ltd
GTX Medical BV
Helius Medical Technologies Inc
Highland Instruments Inc
Imperial College London
ImThera Medical Inc
INBRAIN Neuroelectronics
InCube Labs LLC
Inner Cosmos Inc
InnoSphere Ltd
Inspire Medical Systems Inc
Integer Holdings Corp
Iota Biosciences Inc
Iowa State University
JelikaLite LLC
Johns Hopkins University
Juno Biomedical Inc
King's College London
Koc University
Koninklijke Philips NV
Lawrence Livermore National Laboratory
Lawson Health Research Institute
Lehigh University
Leptos Biomedical, Inc.
LivaNova PLC
Lockheed Martin Aculight Corporation
Louis Stokes Cleveland VA Medical Center
Louisiana State University
Lynx Design, Inc.
Magnus Medical Inc
MagVenture A/S
Massachusetts Eye and Ear Infirmary
Massachusetts General Hospital
Massachusetts Institute of Technology
Mayo Clinic
MDCN Technologies Inc
MDCN Technology Co Ltd
Meagan Medical Inc.
MedAutonomic Inc
Meddynamics Ltd.
Medical University of South Carolina
Medtrode Inc
Medtronic Inc
Medtronic Plc
Medtronic Xomed Inc
MetaCure Germany GmbH
Metavention Inc
Micro-Leads Inc
MicroTransponder Inc
Monash University
Morari LLC
Motility Medical
MR-Link LLC
Myant Inc
Nagoya University Graduate School of Medicine
National Cheng-Kung University Hospital
National University of Ireland Galway
NDI Medical LLC
Nemechek Technologies LLC
Neogenesis Technologies LLC
Nervive Inc
NeuraStasis Inc
Neuro Device Group SA
Neuro Devices, Inc.
Neurodan A/S
Neuroelectrics Barcelona SLU
NeuroEM Therapeutics Inc
Neurolief Ltd.
NeuroMEDx
NeuroMetrix Inc
Neuromod Devices Ltd
Neuronetics Inc
Neuronix Ltd
Neuronoff Inc
NeuroOne Medical Technologies Corp
NeuroPace Inc
Neuroparticle Corp
NeuroPrex Inc
NeuroPro Technologies Inc
NeuroQore, Inc.
Neuros Medical Inc
Neurosigma Inc
Neurostream Technologies G.P. (Inactive)
NeuroTek Medical Inc
Neurotherapeutic Solutions Ltd
NeuroTronik Inc
Neurovalens Ltd
NeuSpera Medical Inc
Neuvotion Inc
Nevro Corp
New Jersey Institute of Technology
Newronika s.r.l.
Nexeon Medsystems Belgium SPRL
Nexeon MedSystems Inc
Nexstim Plc
Nia Therapeutics Inc
Nihon Kohden Corp
Noctrix Health Inc
Northwestern University
Novo Medical Corporation
Nu Eyne Co Ltd
NuroRestore, Inc.
Nuvectra Corp
NYU Langone Health System
Nyxoah SA
Ohio State University
Olympic Ophthalmics Inc
Onward Technologies Ltd
Otto Bock HealthCare GmbH
Parasym Ltd
PathMaker Neurosystems Inc
Phagenesis Ltd
Polytechnique Montreal
Precisis AG
Presidio Medical Inc
Pulsetto UAB
Pulsus Medical LLC (Inactive)
Purdue University
Quantum Nanostim LLC
QV Bioelectronics Ltd
Ratner BioMedical Inc
Realeve LLC
Remedee Labs SAS
ReShape Lifesciences Inc
Rice University
Ripple
Rowan University
Saluda Medical Pty Ltd
Salvia Bioelectronics BV
San Francisco VA Medical Center
Sapiens
Seraya Medical LLC
Shanghai Keku Medical Technology Co Ltd
ShiraTronics Inc
Silere Medical Technology, Inc. (Inactive)
Soin Neuroscience Inc
Sooma Oy
Soterix Medical Inc
Spark Biomedical Inc
SpineX
SPR Therapeutics LLC
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
Stanford University
Stimdia Medical Inc
StimRelieve LLC
Sunnybrook Health Sciences Centre
SUNY Downstate Medical Center
Synchron Inc
SynerFuse Inc
Synergia Medical SA
Tal Medical, Inc.
Teliatry Inc
Texas A&M University
The Alfred Mann Foundation
The Charles Stark Draper Laboratory Inc
The Feinstein Institute for Medical Research
The Magstim Co Ltd
TheraNova LLC
Thync Inc
Trifectas Medical Corp.
Trinity College Dublin
Tristan Technologies Inc
University of Alabama
University of Auckland
University of California Irvine
University of California Los Angeles
University of California San Diego
University of California San Francisco
University of Cambridge
University of Central Florida
University of Colorado
University of Florida
University of Gothenburg
University of Gottingen
University of Helsinki
University of Houston
University of Illinois
University of Kansas
University of Michigan
University of Milan
University of Minnesota
University of North Carolina at Chapel Hill
University of Oxford
University of Pittsburgh
University of Pittsburgh School of Medicine
University of Queensland
University of Rochester
University of South Carolina
University of South Florida
University of Southern California
University of Technology Sydney
University of Texas Health Science Center at Houston
University of Texas Southwestern Medical Center
University of Utah
University of Washington
University of Wisconsin Madison
University of Wollongong
University of Zurich
Uro Medical Corp
Valencia Technologies Corp
Vanderbilt University
Vanderbilt University Medical Center
Virginia Commonwealth University
Wake Forest Baptist Medical Center
Washington University in St Louis
Washington University School of Medicine
Wave Neuroscience Inc
Wavegate Corp
Wayne State University
Wedge Therapeutics
Weizmann Institute of Science
Wisconsin Institute of Nuclear Systems
WISE s.r.l.
Xavant Technology (Pty) Ltd
XN Health Inc
YBrain Inc
Zennea Technologies
Zygood LLC

Table of Contents

1 Table of Contents 3

|1.1 List of Tables 19

|1.2 List of Figures 57

2 Introduction 58

2.1 Neuromodulation Devices Overview 58

3 Products under Development 60

3.1 Neuromodulation Devices – Pipeline Products by Stage of Development 60

3.2 Neuromodulation Devices – Pipeline Products by Segment 61

3.3 Neuromodulation Devices – Pipeline Products by Territory 62

3.4 Neuromodulation Devices – Pipeline Products by Regulatory Path 64

3.5 Neuromodulation Devices – Pipeline Products by Estimated Approval Date 66

3.6 Neuromodulation Devices – Ongoing Clinical Trials 67

4 Neuromodulation Devices – Pipeline Products under Development by Companies 68

4.1 Neuromodulation Devices Companies – Pipeline Products by Stage of Development 68

4.2 Neuromodulation Devices – Pipeline Products by Stage of Development 81

5 Neuromodulation Devices Companies and Product Overview 97

5.1 Aalto University Company Overview 97

5.1.1 Aalto University Pipeline Products & Ongoing Clinical Trials Overview 97

5.2 ab medica spa Company Overview 98

5.2.1 ab medica spa Pipeline Products & Ongoing Clinical Trials Overview 98

5.3 Actegy Ltd. Company Overview 99

5.3.1 Actegy Ltd. Pipeline Products & Ongoing Clinical Trials Overview 99

5.4 Actipulse Neuroscience Inc Company Overview 102

5.4.1 Actipulse Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview 102

5.5 Actuated Medical Inc Company Overview 103

5.5.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 103

5.6 Adaptive Neuromodulation GmbH Company Overview 104

5.6.1 Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview 104

5.7 Adept Neuro SA Company Overview 105

5.7.1 Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview 105

5.8 Adriakaim Inc Company Overview 106

5.8.1 Adriakaim Inc Pipeline Products & Ongoing Clinical Trials Overview 106

5.9 Afferent Corporation Company Overview 107

5.9.1 Afferent Corporation Pipeline Products & Ongoing Clinical Trials Overview 107

5.10 Afferent Technologies Company Overview 108

5.10.1 Afferent Technologies Pipeline Products & Ongoing Clinical Trials Overview 108

5.11 Aleva Neurotherapeutics SA Company Overview 109

5.11.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 109

5.12 Alfa Rhythm Ltd Company Overview 113

5.12.1 Alfa Rhythm Ltd Pipeline Products & Ongoing Clinical Trials Overview 113

5.13 Allegheny Health Network Company Overview 114

5.13.1 Allegheny Health Network Pipeline Products & Ongoing Clinical Trials Overview 114

5.14 Allevion Therapeutics Inc Company Overview 116

5.14.1 Allevion Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 116

5.15 Apnex Medical Inc Company Overview 117

5.15.1 Apnex Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 117

5.16 Attune Neurosciences Inc Company Overview 118

5.16.1 Attune Neurosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 118

5.17 Aucta Technologies Inc Company Overview 119

5.17.1 Aucta Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 119

5.18 AURIMOD GmbH Company Overview 120

5.18.1 AURIMOD GmbH Pipeline Products & Ongoing Clinical Trials Overview 120

5.19 Avation Medical Company Overview 123

5.19.1 Avation Medical Pipeline Products & Ongoing Clinical Trials Overview 123

5.20 Axilum Robotics Company Overview 126

5.20.1 Axilum Robotics Pipeline Products & Ongoing Clinical Trials Overview 126

5.21 Axonic SAS Company Overview 127

5.21.1 Axonic SAS Pipeline Products & Ongoing Clinical Trials Overview 127

5.22 Axonics Inc Company Overview 128

5.22.1 Axonics Inc Pipeline Products & Ongoing Clinical Trials Overview 128

5.23 Barinetics Corporation Company Overview 130

5.23.1 Barinetics Corporation Pipeline Products & Ongoing Clinical Trials Overview 130

5.24 Battelle Memorial Institute Company Overview 131

5.24.1 Battelle Memorial Institute Pipeline Products & Ongoing Clinical Trials Overview 131

5.25 Baylor College of Medicine Company Overview 132

5.25.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 132

5.26 BBB Technologies Inc Company Overview 134

5.26.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 134

5.27 Beijing Lingchuang Yigu Technology Development Co Ltd Company Overview 136

5.27.1 Beijing Lingchuang Yigu Technology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 136

5.28 Beta-Stim LTD Company Overview 137

5.28.1 Beta-Stim LTD Pipeline Products & Ongoing Clinical Trials Overview 137

5.29 BioElectric Solutions Inc. Company Overview 138

5.29.1 BioElectric Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview 138

5.30 Bioinduction Limited Company Overview 139

5.30.1 Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview 139

5.31 Bioness Inc Company Overview 144

5.31.1 Bioness Inc Pipeline Products & Ongoing Clinical Trials Overview 144

5.32 Biophysical Mind Technologies Ltd. Company Overview 147

5.32.1 Biophysical Mind Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 147

5.33 Biospark Technologies Pte Ltd Company Overview 148

5.33.1 Biospark Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 148

5.34 Biotronik AG Company Overview 149

5.34.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview 149

5.35 Biotronik Inc Company Overview 151

5.35.1 Biotronik Inc Pipeline Products & Ongoing Clinical Trials Overview 151

5.36 Biotronik SE & Co KG Company Overview 154

5.36.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 154

5.37 BlueWind Medical Ltd Company Overview 155

5.37.1 BlueWind Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 155

5.38 Boston Children’s Hospital Company Overview 158

5.38.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 158

5.39 Boston Scientific Corp Company Overview 159

5.39.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 159

5.40 BrainsGate Ltd Company Overview 168

5.40.1 BrainsGate Ltd Pipeline Products & Ongoing Clinical Trials Overview 168

5.41 Brainsway Ltd Company Overview 174

5.41.1 Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview 174

5.42 Brazos Biomedical LLC Company Overview 184

5.42.1 Brazos Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview 184

5.43 Brown University Company Overview 185

5.43.1 Brown University Pipeline Products & Ongoing Clinical Trials Overview 185

5.44 Cadence Neuroscience Inc Company Overview 186

5.44.1 Cadence Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview 186

5.45 Cala Health Inc Company Overview 187

5.45.1 Cala Health Inc Pipeline Products & Ongoing Clinical Trials Overview 187

5.46 Callitas Therapeutics Inc Company Overview 191

5.46.1 Callitas Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 191

5.47 Cardionomic Inc Company Overview 192

5.47.1 Cardionomic Inc Pipeline Products & Ongoing Clinical Trials Overview 192

5.48 Carnegie Mellon University Company Overview 195

5.48.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 195

5.49 Catalan Institute of Nanoscience and Nanotechnology Company Overview 196

5.49.1 Catalan Institute of Nanoscience and Nanotechnology Pipeline Products & Ongoing Clinical Trials Overview 196

5.50 Cefaly Technology sprl Company Overview 197

5.50.1 Cefaly Technology sprl Pipeline Products & Ongoing Clinical Trials Overview 197

5.51 Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Company Overview 202

5.51.1 Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Pipeline Products & Ongoing Clinical Trials Overview 202

5.52 CerboMed GmbH Company Overview 203

5.52.1 CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview 203

5.53 Cerebain Biotech Corp Company Overview 204

5.53.1 Cerebain Biotech Corp Pipeline Products & Ongoing Clinical Trials Overview 204

5.54 Cerephex Corporation Company Overview 205

5.54.1 Cerephex Corporation Pipeline Products & Ongoing Clinical Trials Overview 205

5.55 Cerevast Therapeutics Inc Company Overview 206

5.55.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 206

5.56 Charco Neurotech Ltd Company Overview 210

5.56.1 Charco Neurotech Ltd Pipeline Products & Ongoing Clinical Trials Overview 210

5.57 Checkpoint Surgical Inc Company Overview 211

5.57.1 Checkpoint Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 211

5.58 Chordate Medical AB Company Overview 214

5.58.1 Chordate Medical AB Pipeline Products & Ongoing Clinical Trials Overview 214

5.59 Cibiem, Inc. Company Overview 217

5.59.1 Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview 217

5.60 Cirtec Medical Corp Company Overview 218

5.60.1 Cirtec Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 218

5.61 ClearPoint Medical Company Overview 221

5.61.1 ClearPoint Medical Pipeline Products & Ongoing Clinical Trials Overview 221

5.62 ClearPoint Neuro Inc Company Overview 222

5.62.1 ClearPoint Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview 222

5.63 Cleveland Clinic Company Overview 227

5.63.1 Cleveland Clinic Pipeline Products & Ongoing Clinical Trials Overview 227

5.64 Cleveland Medical Devices Inc Company Overview 228

5.64.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 228

5.65 Clinatec Company Overview 230

5.65.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview 230

5.66 CNX Medical Inc Company Overview 232

5.66.1 CNX Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 232

5.67 Cognito Therapeutics Inc Company Overview 233

5.67.1 Cognito Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 233

5.68 Coloplast A/S Company Overview 236

5.68.1 Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 236

5.69 Columbia Engineering Company Overview 240

5.69.1 Columbia Engineering Pipeline Products & Ongoing Clinical Trials Overview 240

5.70 Columbia University Company Overview 241

5.70.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 241

5.71 Comphya SA Company Overview 242

5.71.1 Comphya SA Pipeline Products & Ongoing Clinical Trials Overview 242

5.72 Conservocare, LLC Company Overview 243

5.72.1 Conservocare, LLC Pipeline Products & Ongoing Clinical Trials Overview 243

5.73 Coridea, LLC Company Overview 244

5.73.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 244

5.74 Cortec GmbH Company Overview 247

5.74.1 Cortec GmbH Pipeline Products & Ongoing Clinical Trials Overview 247

5.75 Cortivis Company Overview 250

5.75.1 Cortivis Pipeline Products & Ongoing Clinical Trials Overview 250

5.76 Cyberonics Inc Company Overview 253

5.76.1 Cyberonics Inc Pipeline Products & Ongoing Clinical Trials Overview 253

5.77 Deep Brain Innovations, LLC Company Overview 254

5.77.1 Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 254

5.78 Deep Brain Stimulation Technologies Pty Ltd Company Overview 259

5.78.1 Deep Brain Stimulation Technologies Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 259

5.79 DEYMED Diagnostic Company Overview 260

5.79.1 DEYMED Diagnostic Pipeline Products & Ongoing Clinical Trials Overview 260

5.80 Dignify Therapeutics LLC Company Overview 265

5.80.1 Dignify Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 265

5.81 Direct Spinal Therapeutics, Inc. Company Overview 266

5.81.1 Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 266

5.82 Drexel University Company Overview 267

5.82.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 267

5.83 Duke University Company Overview 268

5.83.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 268

5.84 DuoCure Ltd. Company Overview 270

5.84.1 DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview 270

5.85 Dysphagia Company Overview 271

5.85.1 Dysphagia Pipeline Products & Ongoing Clinical Trials Overview 271

5.86 EBS Technologies GmbH Company Overview 272

5.86.1 EBS Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 272

5.87 EBT Medical Inc Company Overview 274

5.87.1 EBT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 274

5.88 Ecole Polytechnique Federale de Lausanne Company Overview 275

5.88.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 275

5.89 Eisana Corp Company Overview 276

5.89.1 Eisana Corp Pipeline Products & Ongoing Clinical Trials Overview 276

5.90 ElectroCore Inc Company Overview 277

5.90.1 ElectroCore Inc Pipeline Products & Ongoing Clinical Trials Overview 277

5.91 Elira Therapeutics Inc Company Overview 294

5.91.1 Elira Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 294

5.92 EMKinetics, Inc. Company Overview 295

5.92.1 EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 295

5.93 Emory University School of Medicine Company Overview 299

5.93.1 Emory University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 299

5.94 Endonovo Therapeutics Inc Company Overview 300

5.94.1 Endonovo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 300

5.95 EndoStim Inc Company Overview 302

5.95.1 EndoStim Inc Pipeline Products & Ongoing Clinical Trials Overview 302

5.96 Enlight Medical Technologies (Shanghai) Co Ltd Company Overview 303

5.96.1 Enlight Medical Technologies (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 303

5.97 Enopace Biomedical Ltd Company Overview 304

5.97.1 Enopace Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 304

5.98 Enspire DBS Therapy Inc Company Overview 309

5.98.1 Enspire DBS Therapy Inc Pipeline Products & Ongoing Clinical Trials Overview 309

5.99 EPIC Neuro Inc Company Overview 312

5.99.1 EPIC Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview 312

5.100 Epineuron Technologies Inc Company Overview 313

5.100.1 Epineuron Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 313

5.101 EstimME Ltd. Company Overview 316

5.101.1 EstimME Ltd. Pipeline Products & Ongoing Clinical Trials Overview 316

5.102 Evonik Corp Company Overview 317

5.102.1 Evonik Corp Pipeline Products & Ongoing Clinical Trials Overview 317

5.103 Evren Technologies Inc Company Overview 318

5.103.1 Evren Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 318

5.104 Exsurgo Ltd Company Overview 319

5.104.1 Exsurgo Ltd Pipeline Products & Ongoing Clinical Trials Overview 319

5.105 Feelmore Labs Inc Company Overview 323

5.105.1 Feelmore Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 323

5.106 FemPulse LLC Company Overview 324

5.106.1 FemPulse LLC Pipeline Products & Ongoing Clinical Trials Overview 324

5.107 Fisher Wallace Laboratories, LLC Company Overview 327

5.107.1 Fisher Wallace Laboratories, LLC Pipeline Products & Ongoing Clinical Trials Overview 327

5.108 Flint Rehabilitation Company Overview 328

5.108.1 Flint Rehabilitation Pipeline Products & Ongoing Clinical Trials Overview 328

5.109 Florida International University Company Overview 329

5.109.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview 329

5.110 Flow Neuroscience AB Company Overview 330

5.110.1 Flow Neuroscience AB Pipeline Products & Ongoing Clinical Trials Overview 330

5.111 FRD Accel LLC Company Overview 333

5.111.1 FRD Accel LLC Pipeline Products & Ongoing Clinical Trials Overview 333

5.112 Functional Neuromodulation Inc. Company Overview 334

5.112.1 Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview 334

5.113 Futurecure Health Pvt Ltd Company Overview 335

5.113.1 Futurecure Health Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 335

5.114 G6 Technologies Corporation Company Overview 336

5.114.1 G6 Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 336

5.115 Galvani Bioelectronics Ltd Company Overview 337

5.115.1 Galvani Bioelectronics Ltd Pipeline Products & Ongoing Clinical Trials Overview 337

5.116 Georgia Institute of Technology Company Overview 340

5.116.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 340

5.117 Ghoonuts Co Ltd Company Overview 341

5.117.1 Ghoonuts Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 341

5.118 GiMer Medical Company Overview 342

5.118.1 GiMer Medical Pipeline Products & Ongoing Clinical Trials Overview 342

5.119 Gondola Medical Technologies SA Company Overview 345

5.119.1 Gondola Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 345

5.120 GrayMatters Health Ltd Company Overview 348

5.120.1 GrayMatters Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 348

5.121 GTX Medical BV Company Overview 349

5.121.1 GTX Medical BV Pipeline Products & Ongoing Clinical Trials Overview 349

5.122 Helius Medical Technologies Inc Company Overview 352

5.122.1 Helius Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 352

5.123 Highland Instruments Inc Company Overview 363

5.123.1 Highland Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 363

5.124 Imperial College London Company Overview 370

5.124.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 370

5.125 ImThera Medical Inc Company Overview 373

5.125.1 ImThera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 373

5.126 INBRAIN Neuroelectronics Company Overview 376

5.126.1 INBRAIN Neuroelectronics Pipeline Products & Ongoing Clinical Trials Overview 376

5.127 InCube Labs LLC Company Overview 377

5.127.1 InCube Labs LLC Pipeline Products & Ongoing Clinical Trials Overview 377

5.128 Inner Cosmos Inc Company Overview 378

5.128.1 Inner Cosmos Inc Pipeline Products & Ongoing Clinical Trials Overview 378

5.129 InnoSphere Ltd Company Overview 381

5.129.1 InnoSphere Ltd Pipeline Products & Ongoing Clinical Trials Overview 381

5.130 Inspire Medical Systems Inc Company Overview 384

5.130.1 Inspire Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 384

5.131 Integer Holdings Corp Company Overview 385

5.131.1 Integer Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 385

5.132 Iota Biosciences Inc Company Overview 387

5.132.1 Iota Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 387

5.133 Iowa State University Company Overview 390

5.133.1 Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 390

5.134 JelikaLite LLC Company Overview 392

5.134.1 JelikaLite LLC Pipeline Products & Ongoing Clinical Trials Overview 392

5.135 Johns Hopkins University Company Overview 395

5.135.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 395

5.136 Juno Biomedical Inc Company Overview 398

5.136.1 Juno Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 398

5.137 King’s College London Company Overview 399

5.137.1 King’s College London Pipeline Products & Ongoing Clinical Trials Overview 399

5.138 Koc University Company Overview 400

5.138.1 Koc University Pipeline Products & Ongoing Clinical Trials Overview 400

5.139 Koninklijke Philips NV Company Overview 401

5.139.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview 401

5.140 Lawrence Livermore National Laboratory Company Overview 403

5.140.1 Lawrence Livermore National Laboratory Pipeline Products & Ongoing Clinical Trials Overview 403

5.141 Lawson Health Research Institute Company Overview 404

5.141.1 Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview 404

5.142 Lehigh University Company Overview 405

5.142.1 Lehigh University Pipeline Products & Ongoing Clinical Trials Overview 405

5.143 Leptos Biomedical, Inc. Company Overview 406

5.143.1 Leptos Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 406

5.144 LivaNova PLC Company Overview 407

5.144.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 407

5.145 Lockheed Martin Aculight Corporation Company Overview 417

5.145.1 Lockheed Martin Aculight Corporation Pipeline Products & Ongoing Clinical Trials Overview 417

5.146 Louis Stokes Cleveland VA Medical Center Company Overview 418

5.146.1 Louis Stokes Cleveland VA Medical Center Pipeline Products & Ongoing Clinical Trials Overview 418

5.147 Louisiana State University Company Overview 419

5.147.1 Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview 419

5.148 Lynx Design, Inc. Company Overview 420

5.148.1 Lynx Design, Inc. Pipeline Products & Ongoing Clinical Trials Overview 420

5.149 Magnus Medical Inc Company Overview 422

5.149.1 Magnus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 422

5.150 MagVenture A/S Company Overview 423

5.150.1 MagVenture A/S Pipeline Products & Ongoing Clinical Trials Overview 423

5.151 Massachusetts Eye and Ear Infirmary Company Overview 429

5.151.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 429

5.152 Massachusetts General Hospital Company Overview 430

5.152.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 430

5.153 Massachusetts Institute of Technology Company Overview 432

5.153.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 432

5.154 Mayo Clinic Company Overview 434

5.154.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 434

5.155 MDCN Technologies Inc Company Overview 436

5.155.1 MDCN Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 436

5.156 MDCN Technology Co Ltd Company Overview 437

5.156.1 MDCN Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 437

5.157 Meagan Medical Inc. Company Overview 440

5.157.1 Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 440

5.158 MedAutonomic Inc Company Overview 441

5.158.1 MedAutonomic Inc Pipeline Products & Ongoing Clinical Trials Overview 441

5.159 Meddynamics Ltd. Company Overview 442

5.159.1 Meddynamics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 442

5.160 Medical University of South Carolina Company Overview 443

5.160.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 443

5.161 Medtrode Inc Company Overview 448

5.161.1 Medtrode Inc Pipeline Products & Ongoing Clinical Trials Overview 448

5.162 Medtronic Inc Company Overview 449

5.162.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview 449

5.163 Medtronic Plc Company Overview 452

5.163.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 452

5.164 Medtronic Xomed Inc Company Overview 464

5.164.1 Medtronic Xomed Inc Pipeline Products & Ongoing Clinical Trials Overview 464

5.165 MetaCure Germany GmbH Company Overview 465

5.165.1 MetaCure Germany GmbH Pipeline Products & Ongoing Clinical Trials Overview 465

5.166 Metavention Inc Company Overview 466

5.166.1 Metavention Inc Pipeline Products & Ongoing Clinical Trials Overview 466

5.167 Micro-Leads Inc Company Overview 469

5.167.1 Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview 469

5.168 MicroTransponder Inc Company Overview 472

5.168.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview 472

5.169 Monash University Company Overview 477

5.169.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 477

5.170 Morari LLC Company Overview 478

5.170.1 Morari LLC Pipeline Products & Ongoing Clinical Trials Overview 478

5.171 Motility Medical Company Overview 479

5.171.1 Motility Medical Pipeline Products & Ongoing Clinical Trials Overview 479

5.172 MR-Link LLC Company Overview 482

5.172.1 MR-Link LLC Pipeline Products & Ongoing Clinical Trials Overview 482

5.173 Myant Inc Company Overview 483

5.173.1 Myant Inc Pipeline Products & Ongoing Clinical Trials Overview 483

5.174 Nagoya University Graduate School of Medicine Company Overview 484

5.174.1 Nagoya University Graduate School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 484

5.175 National Cheng-Kung University Hospital Company Overview 485

5.175.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 485

5.176 National University of Ireland Galway Company Overview 486

5.176.1 National University of Ireland Galway Pipeline Products & Ongoing Clinical Trials Overview 486

5.177 NDI Medical LLC Company Overview 488

5.177.1 NDI Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 488

5.178 Nemechek Technologies LLC Company Overview 489

5.178.1 Nemechek Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 489

5.179 Neogenesis Technologies LLC Company Overview 490

5.179.1 Neogenesis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 490

5.180 Nervive Inc Company Overview 491

5.180.1 Nervive Inc Pipeline Products & Ongoing Clinical Trials Overview 491

5.181 NeuraStasis Inc Company Overview 496

5.181.1 NeuraStasis Inc Pipeline Products & Ongoing Clinical Trials Overview 496

5.182 Neuro Device Group SA Company Overview 497

5.182.1 Neuro Device Group SA Pipeline Products & Ongoing Clinical Trials Overview 497

5.183 Neuro Devices, Inc. Company Overview 498

5.183.1 Neuro Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 498

5.184 Neurodan A/S Company Overview 500

5.184.1 Neurodan A/S Pipeline Products & Ongoing Clinical Trials Overview 500

5.185 Neuroelectrics Barcelona SLU Company Overview 501

5.185.1 Neuroelectrics Barcelona SLU Pipeline Products & Ongoing Clinical Trials Overview 501

5.186 NeuroEM Therapeutics Inc Company Overview 507

5.186.1 NeuroEM Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 507

5.187 Neurolief Ltd. Company Overview 510

5.187.1 Neurolief Ltd. Pipeline Products & Ongoing Clinical Trials Overview 510

5.188 NeuroMEDx Company Overview 513

5.188.1 NeuroMEDx Pipeline Products & Ongoing Clinical Trials Overview 513

5.189 NeuroMetrix Inc Company Overview 514

5.189.1 NeuroMetrix Inc Pipeline Products & Ongoing Clinical Trials Overview 514

5.190 Neuromod Devices Ltd Company Overview 524

5.190.1 Neuromod Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 524

5.191 Neuronetics Inc Company Overview 527

5.191.1 Neuronetics Inc Pipeline Products & Ongoing Clinical Trials Overview 527

5.192 Neuronix Ltd Company Overview 537

5.192.1 Neuronix Ltd Pipeline Products & Ongoing Clinical Trials Overview 537

5.193 Neuronoff Inc Company Overview 539

5.193.1 Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview 539

5.194 NeuroOne Medical Technologies Corp Company Overview 542

5.194.1 NeuroOne Medical Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview 542

5.195 NeuroPace Inc Company Overview 545

5.195.1 NeuroPace Inc Pipeline Products & Ongoing Clinical Trials Overview 545

5.196 Neuroparticle Corp Company Overview 551

5.196.1 Neuroparticle Corp Pipeline Products & Ongoing Clinical Trials Overview 551

5.197 NeuroPrex Inc Company Overview 552

5.197.1 NeuroPrex Inc Pipeline Products & Ongoing Clinical Trials Overview 552

5.198 NeuroPro Technologies Inc Company Overview 553

5.198.1 NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 553

5.199 NeuroQore, Inc. Company Overview 554

5.199.1 NeuroQore, Inc. Pipeline Products & Ongoing Clinical Trials Overview 554

5.200 Neuros Medical Inc Company Overview 557

5.200.1 Neuros Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 557

5.201 Neurosigma Inc Company Overview 559

5.201.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 559

5.202 Neurostream Technologies G.P. (Inactive) Company Overview 570

5.202.1 Neurostream Technologies G.P. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 570

5.203 NeuroTek Medical Inc Company Overview 571

5.203.1 NeuroTek Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 571

5.204 Neurotherapeutic Solutions Ltd Company Overview 572

5.204.1 Neurotherapeutic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 572

5.205 NeuroTronik Inc Company Overview 575

5.205.1 NeuroTronik Inc Pipeline Products & Ongoing Clinical Trials Overview 575

5.206 Neurovalens Ltd Company Overview 578

5.206.1 Neurovalens Ltd Pipeline Products & Ongoing Clinical Trials Overview 578

5.207 NeuSpera Medical Inc Company Overview 586

5.207.1 NeuSpera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 586

5.208 Neuvotion Inc Company Overview 589

5.208.1 Neuvotion Inc Pipeline Products & Ongoing Clinical Trials Overview 589

5.209 Nevro Corp Company Overview 590

5.209.1 Nevro Corp Pipeline Products & Ongoing Clinical Trials Overview 590

5.210 New Jersey Institute of Technology Company Overview 608

5.210.1 New Jersey Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 608

5.211 Newronika s.r.l. Company Overview 609

5.211.1 Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 609

5.212 Nexeon Medsystems Belgium SPRL Company Overview 612

5.212.1 Nexeon Medsystems Belgium SPRL Pipeline Products & Ongoing Clinical Trials Overview 612

5.213 Nexeon MedSystems Inc Company Overview 613

5.213.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 613

5.214 Nexstim Plc Company Overview 618

5.214.1 Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview 618

5.215 Nia Therapeutics Inc Company Overview 624

5.215.1 Nia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 624

5.216 Nihon Kohden Corp Company Overview 625

5.216.1 Nihon Kohden Corp Pipeline Products & Ongoing Clinical Trials Overview 625

5.217 Noctrix Health Inc Company Overview 626

5.217.1 Noctrix Health Inc Pipeline Products & Ongoing Clinical Trials Overview 626

5.218 Northwestern University Company Overview 629

5.218.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 629

5.219 Novo Medical Corporation Company Overview 632

5.219.1 Novo Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 632

5.220 Nu Eyne Co Ltd Company Overview 633

5.220.1 Nu Eyne Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 633

5.221 NuroRestore, Inc. Company Overview 639

5.221.1 NuroRestore, Inc. Pipeline Products & Ongoing Clinical Trials Overview 639

5.222 Nuvectra Corp Company Overview 640

5.222.1 Nuvectra Corp Pipeline Products & Ongoing Clinical Trials Overview 640

5.223 NYU Langone Health System Company Overview 642

5.223.1 NYU Langone Health System Pipeline Products & Ongoing Clinical Trials Overview 642

5.224 Nyxoah SA Company Overview 644

5.224.1 Nyxoah SA Pipeline Products & Ongoing Clinical Trials Overview 644

5.225 Ohio State University Company Overview 650

5.225.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 650

5.226 Olympic Ophthalmics Inc Company Overview 651

5.226.1 Olympic Ophthalmics Inc Pipeline Products & Ongoing Clinical Trials Overview 651

5.227 Onward Technologies Ltd Company Overview 655

5.227.1 Onward Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 655

5.228 Otto Bock HealthCare GmbH Company Overview 664

5.228.1 Otto Bock HealthCare GmbH Pipeline Products & Ongoing Clinical Trials Overview 664

5.229 Parasym Ltd Company Overview 666

5.229.1 Parasym Ltd Pipeline Products & Ongoing Clinical Trials Overview 666

5.230 PathMaker Neurosystems Inc Company Overview 670

5.230.1 PathMaker Neurosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 670

5.231 Phagenesis Ltd Company Overview 674

5.231.1 Phagenesis Ltd Pipeline Products & Ongoing Clinical Trials Overview 674

5.232 Polytechnique Montreal Company Overview 677

5.232.1 Polytechnique Montreal Pipeline Products & Ongoing Clinical Trials Overview 677

5.233 Precisis AG Company Overview 680

5.233.1 Precisis AG Pipeline Products & Ongoing Clinical Trials Overview 680

5.234 Presidio Medical Inc Company Overview 681

5.234.1 Presidio Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 681

5.235 Pulsetto UAB Company Overview 682

5.235.1 Pulsetto UAB Pipeline Products & Ongoing Clinical Trials Overview 682

5.236 Pulsus Medical LLC (Inactive) Company Overview 683

5.236.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 683

5.237 Purdue University Company Overview 684

5.237.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 684

5.238 Quantum Nanostim LLC Company Overview 685

5.238.1 Quantum Nanostim LLC Pipeline Product

Table

Neuromodulation Devices – Pipeline Products by Stage of Development 60

Neuromodulation Devices – Pipeline Products by Segment 61

Neuromodulation Devices – Pipeline Products by Territory 62

Neuromodulation Devices – Pipeline Products by Regulatory Path 64

Neuromodulation Devices – Pipeline Products by Estimated Approval Date 66

Neuromodulation Devices – Ongoing Clinical Trials 67

Neuromodulation Devices Companies – Pipeline Products by Stage of Development 68

Neuromodulation Devices – Pipeline Products by Stage of Development 81

Aalto University Pipeline Products & Ongoing Clinical Trials Overview 97

Multi-Locus Transcranial Magnetic Stimulation Device – Product Status 97

Multi-Locus Transcranial Magnetic Stimulation Device – Product Description 97

ab medica spa Pipeline Products & Ongoing Clinical Trials Overview 98

Cyberbrain – Product Status 98

Cyberbrain – Product Description 98

Actegy Ltd. Pipeline Products & Ongoing Clinical Trials Overview 99

Revitive – Product Status 99

Revitive – Product Description 99

Actegy Ltd. – Ongoing Clinical Trials Overview 100

Revitive – A Double Blind, Randomized, Sham-controlled Trial Investigating the Effects of Combining Electrical Stimulation of the Calf and Thigh Muscles in Patients with Osteoarthritis of the Knee 101

Revitive – Haemodynamic Changes in Femoral-popliteal Bypass Grafts with the Use of Neuromuscular Electrical Stimulation 101

Revitive – The Effect of an Eight-week Treatment Programme Using Foot Electrical Muscle Stimulator (EMS) on Physical Function and Leg Symptoms in Community Dwelling Older Adults: A Randomized Controlled Trial 101

Actipulse Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview 102

Fast Gamma Magnetic Stimulation Device – Product Status 102

Fast Gamma Magnetic Stimulation Device – Product Description 102

Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 103

Peripheral Nerve Targeting System – Product Status 103

Peripheral Nerve Targeting System – Product Description 103

Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview 104

CR-Capable Implant – Product Status 104

CR-Capable Implant – Product Description 104

Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview 105

Stereo-Electro-Encephalo-Graphie Electrode – Product Status 105

Stereo-Electro-Encephalo-Graphie Electrode – Product Description 105

Adriakaim Inc Pipeline Products & Ongoing Clinical Trials Overview 106

Vagus Nerve Stimulation Device – Product Status 106

Vagus Nerve Stimulation Device – Product Description 106

Afferent Corporation Pipeline Products & Ongoing Clinical Trials Overview 107

Noninvasive Device – Sensory Enhancement – Product Status 107

Noninvasive Device – Sensory Enhancement – Product Description 107

Afferent Technologies Pipeline Products & Ongoing Clinical Trials Overview 108

WiNerve4 System – Product Status 108

WiNerve4 System – Product Description 108

Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 109

cortiSTIM – Product Status 109

cortiSTIM – Product Description 109

directSTIM – Product Status 110

directSTIM – Product Description 110

Aleva Neurotherapeutics SA – Ongoing Clinical Trials Overview 111

directSTIM – A Prospective, Multi-center, Post-market Clinical Follow-up Study of the directSTIM Deep Brain Stimulation (DBS) System 112

Alfa Rhythm Ltd Pipeline Products & Ongoing Clinical Trials Overview 113

Trans-Cranial Electro-Biometric Stimulator – Product Status 113

Trans-Cranial Electro-Biometric Stimulator – Product Description 113

Allegheny Health Network Pipeline Products & Ongoing Clinical Trials Overview 114

Deep Brain Stimulation System – Alzheimer’s Disease – Product Status 114

Deep Brain Stimulation System – Alzheimer’s Disease – Product Description 114

Deep Brain Stimulation System – Obesity – Product Status 115

Deep Brain Stimulation System – Obesity – Product Description 115

Allevion Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 116

Allevx Smart Wrist-Cuff – Product Status 116

Allevx Smart Wrist-Cuff – Product Description 116

Apnex Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 117

Second Generation HGNS System – Product Status 117

Second Generation HGNS System – Product Description 117

Attune Neurosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 118

Transcranial Ultrasound Device – Opioid Use Disorder – Product Status 118

Transcranial Ultrasound Device – Opioid Use Disorder – Product Description 118

Aucta Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 119

DECIMA Device – Product Status 119

DECIMA Device – Product Description 119

AURIMOD GmbH Pipeline Products & Ongoing Clinical Trials Overview 120

AuriMod – Product Status 120

AuriMod – Product Description 120

AURIMOD GmbH – Ongoing Clinical Trials Overview 121

AuriMod – Personalized Auricular Vagus Nerve Stimulation in Patients with Intractable Chronic Low Back Pain: A Randomized Controlled Pilot Study 122

Avation Medical Pipeline Products & Ongoing Clinical Trials Overview 123

Avation System – Product Status 123

Avation System – Product Description 123

Avation Medical – Ongoing Clinical Trials Overview 124

Avation System – A Prospective, Sham-controlled, Safety and Efficacy Study of a Smart, Self-adjusting, Surgery-free, Wearable Bladder Modulation and Digital Health System With Objective Confirmation of Nerve Activation for Use in Home by Subjects With Overactive Bladder Syndrome 125

Axilum Robotics Pipeline Products & Ongoing Clinical Trials Overview 126

TMS-Robot – Product Status 126

TMS-Robot – Product Description 126

Axonic SAS Pipeline Products & Ongoing Clinical Trials Overview 127

Neurostimulation System – Phantom Limb Pain – Product Status 127

Neurostimulation System – Phantom Limb Pain – Product Description 127

Axonics Inc Pipeline Products & Ongoing Clinical Trials Overview 128

Non-Rechargeable Implantable Sacral Neurostimulator – Product Status 128

Non-Rechargeable Implantable Sacral Neurostimulator – Product Description 129

Barinetics Corporation Pipeline Products & Ongoing Clinical Trials Overview 130

GastroPace – Product Status 130

GastroPace – Product Description 130

Battelle Memorial Institute Pipeline Products & Ongoing Clinical Trials Overview 131

Neural Tourniquet – Product Status 131

Neural Tourniquet – Product Description 131

Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 132

Adaptive Deep Brain Stimulation (aDBS) Device – Product Status 132

Adaptive Deep Brain Stimulation (aDBS) Device – Product Description 132

Wireless Endovascular Nerve Stimulator – Product Status 133

Wireless Endovascular Nerve Stimulator – Product Description 133

BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 134

Neurogear – Product Status 134

Neurogear – Product Description 134

Neurogear Pro – Product Status 135

Neurogear Pro – Product Description 135

Beijing Lingchuang Yigu Technology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 136

Neural Electrical Stimulation Device – Pain – Product Status 136

Neural Electrical Stimulation Device – Pain – Product Description 136

Beta-Stim LTD Pipeline Products & Ongoing Clinical Trials Overview 137

BALANCE System Intestinal Electrical Stimulator – Product Status 137

BALANCE System Intestinal Electrical Stimulator – Product Description 137

BioElectric Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview 138

Non-Invasive Neural Stimulator – Product Status 138

Non-Invasive Neural Stimulator – Product Description 138

Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview 139

Picostim – Product Status 139

Picostim – Product Description 139

Picostim-DyNeuMo – Product Status 140

Picostim-DyNeuMo – Product Description 140

Bioinduction Limited – Ongoing Clinical Trials Overview 141

Picostim – Simpler and Safer Deep Brain Stimulation for Parkinson’s Disease 142

Picostim-DyNeuMo – Exploratory Safety and Electrophysiological Study of Closed-loop Pudendal Neuromodulation Using an Implantable (Picostim-DyNeuMo) Device in Women With Urinary Incontinence 143

Bioness Inc Pipeline Products & Ongoing Clinical Trials Overview 144

Bioness Battery Powered Microstimulator – Product Status 144

Bioness Battery Powered Microstimulator – Product Description 144

L300 Go System – Home Use – Product Status 145

L300 Go System – Home Use – Product Description 145

StimRouter – Overactive Bladder – Product Status 145

StimRouter – Overactive Bladder – Product Description 146

Talismann PNS Device – Product Status 146

Talismann PNS Device – Product Description 146

Biophysical Mind Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 147

CES System – Product Status 147

CES System – Product Description 147

Biospark Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 148

Wireless Implantable Device – Chronic Pain Management – Product Status 148

Wireless Implantable Device – Chronic Pain Management – Product Description 148

Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview 149

Resilience – Product Status 149

Resilience – Product Description 149

Truelock – Product Status 149

Truelock – Product Description 150

Biotronik Inc Pipeline Products & Ongoing Clinical Trials Overview 151

Prospera SCS System – Product Status 151

Prospera SCS System – Product Description 151

Biotronik Inc – Ongoing Clinical Trials Overview 152

Prospera SCS System – BENEFIT-03 Clinical Study 153

Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 154

Allevia – Product Status 154

Allevia – Product Description 154

BlueWind Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 155

RENOVA iStim System – Product Status 155

RENOVA iStim System – Product Description 155

BlueWind Medical Ltd – Ongoing Clinical Trials Overview 156

RENOVA iStim System – A Prospective Study to Assess the Efficacy and Safety of the BlueWind RENOVA iStim System in the Treatment of Patients Diagnosed With Overactive Bladder (OASIS – OverActive Bladder Stimulation System Study) 157

Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 158

rTMS H-Coil – Product Status 158

rTMS H-Coil – Product Description 158

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 159

AMT System – Product Status 159

AMT System – Product Description 160

Bion Microstimulator System – Chronic Headache – Product Status 160

Bion Microstimulator System – Chronic Headache – Product Description 160

Deep Brain Stimulation Device – Depression – Product Status 161

Deep Brain Stimulation Device – Depression – Product Description 161

Deep Brain Stimulation Device – Stroke – Product Status 161

Deep Brain Stimulation Device – Stroke – Product Description 161

Enspire DBS Therapy System – Traumatic Brain Injury – Product Status 162

Enspire DBS Therapy System – Traumatic Brain Injury – Product Description 162

MRI-Safe Implantable Neuro Lead – Product Status 162

MRI-Safe Implantable Neuro Lead – Product Description 162

Next Generation DBS System – Product Status 163

Next Generation DBS System – Product Description 163

Next Generation SCS System – Product Status 163

Next Generation SCS System – Product Description 163

Precision Implantable Neurostimulator – Migraine – Product Status 164

Precision Implantable Neurostimulator – Migraine – Product Description 164

Vagus Nerve Stimulation (VNS) System – Product Status 164

Vagus Nerve Stimulation (VNS) System – Product Description 165

Vercise Deep Brain Stimulation System – Alzheimer’s Disease – Product Status 165

Vercise Deep Brain Stimulation System – Alzheimer’s Disease – Product Description 165

Boston Scientific Corp – Ongoing Clinical Trials Overview 166

Vagus Nerve Stimulation (VNS) System – Neural Cardiac Therapy for Heart Failure Study 167

BrainsGate Ltd Pipeline Products & Ongoing Clinical Trials Overview 168

Ischemic Stroke System – Product Status 168

Ischemic Stroke System – Product Description 168

Neuropath System – Glioblastoma Multiforme – Product Status 169

Neuropath System – Glioblastoma Multiforme – Product Description 169

Neuropath System – Vascular Dementia – Product Status 169

Neuropath System – Vascular Dementia – Product Description 170

BrainsGate Ltd – Ongoing Clinical Trials Overview 171

Ischemic Stroke System – A Multicenter, Randomized, Double Blind, Sham Controlled Trial to Assess the Efficacy of the Ischemic Stroke System (ISS) in Preventing Progressive Reduction of Salvageable Brain Tissue Volume in Subjects with Acute Ischemic Stroke 172

Neuropath System – Glioblastoma Multiforme – A Multicenter Prospective Study Safety and Feasibility of Neuropath Activation During Chemiotherapy on Inoperable and Recurrent Glioblastoma Multiforme Patients 173

Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview 174

Deep TMS System – Alcohol Use Disorder – Product Status 174

Deep TMS System – Alcohol Use Disorder – Product Description 175

Deep TMS System – Alzheimer’s Disease – Product Status 175

Deep TMS System – Alzheimer’s Disease – Product Description 175

Deep TMS System – Bipolar Disorder – Product Status 176

Deep TMS System – Bipolar Disorder – Product Description 176

Deep TMS System – Chronic Pain – Product Status 176

Deep TMS System – Chronic Pain – Product Description 177

Deep TMS System – Multiple Sclerosis – Product Status 177

Deep TMS System – Multiple Sclerosis – Product Description 177

Deep TMS System – Obesity – Product Status 178

Deep TMS System – Obesity – Product Description 178

Deep TMS System – Opioid Use Disorder – Product Status 178

Deep TMS System – Opioid Use Disorder – Product Description 179

Deep TMS System – Post-Stroke – Product Status 179

Deep TMS System – Post-Stroke – Product Description 179

Deep TMS System – PTSD – Product Status 180

Deep TMS System – PTSD – Product Description 180

Next-Generation Multi-Channel TMS Stimulator – Product Status 180

Next-Generation Multi-Channel TMS Stimulator – Product Description 181

Brainsway Ltd – Ongoing Clinical Trials Overview 182

Deep TMS System – Bipolar Disorder – A Prospective, Double Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation (TMS) in Conjunction with Mood Stabilizers in Subjects with Bipolar Depression 183

Brazos Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview 184

AURACIS TENS Migraine Management System – Product Status 184

AURACIS TENS Migraine Management System – Product Description 184

Brown University Pipeline Products & Ongoing Clinical Trials Overview 185

Implantable Neural Recording And Stimulation Microsystem – Product Status 185

Implantable Neural Recording And Stimulation Microsystem – Product Description 185

Cadence Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview 186

Next Generation Implantable Device – Epilepsy – Product Status 186

Next Generation Implantable Device – Epilepsy – Product Description 186

Cala Health Inc Pipeline Products & Ongoing Clinical Trials Overview 187

Cala Trio – Action Tremor – Product Status 187

Cala Trio – Action Tremor – Product Description 187

Wearable Neuromodulation Device – Product Status 188

Wearable Neuromodulation Device – Product Description 188

Wearable Neuromodulation Device – Cardiology – Product Status 188

Wearable Neuromodulation Device – Cardiology – Product Description 188

Wearable Neuromodulation Device – Motor Function – Product Status 189

Wearable Neuromodulation Device – Motor Function – Product Description 189

Wearable Neuromodulation Device – Psychiatry – Product Status 189

Wearable Neuromodulation Device – Psychiatry – Product Description 190

Callitas Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 191

Trimtec Gastric Stimulation System – Product Status 191

Trimtec Gastric Stimulation System – Product Description 191

Cardionomic Inc Pipeline Products & Ongoing Clinical Trials Overview 192

Cardiac Pulmonary Nerve Stimulation (CPNS) System – Product Status 192

Cardiac Pulmonary Nerve Stimulation (CPNS) System – Product Description 192

Cardionomic Inc – Ongoing Clinical Trials Overview 193

Cardiac Pulmonary Nerve Stimulation (CPNS) System – Cardiac Pulmonary Nerve Stimulation in Acute Decompensated Heart Failure 194

Cardiac Pulmonary Nerve Stimulation (CPNS) System – The Cardiac Pulmonary Nerve Stimulation (CPNS) Pilot Study 194

Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 195

tFUS Device – Product Status 195

tFUS Device – Product Description 195

Catalan Institute of Nanoscience and Nanotechnology Pipeline Products & Ongoing Clinical Trials Overview 196

Neuroprosthetic Cortical Device – Product Status 196

Neuroprosthetic Cortical Device – Product Description 196

Cefaly Technology sprl Pipeline Products & Ongoing Clinical Trials Overview 197

Cefaly Cluster – Product Status 197

Cefaly Cluster – Product Description 197

Cefaly Coma – Product Status 198

Cefaly Coma – Product Description 198

Cefaly Neuro – Fibromyalgia – Product Status 198

Cefaly Neuro – Fibromyalgia – Product Description 199

Cefaly PREVENT – Chronic Migraine – Product Status 199

Cefaly PREVENT – Chronic Migraine – Product Description 199

Proto – Epilepsy – Product Status 200

Proto – Epilepsy – Product Description 200

Proto – Post Concussion – Product Status 200

Proto – Post Concussion – Product Description 201

Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Pipeline Products & Ongoing Clinical Trials Overview 202

Thermomagnetic Applicator – Product Status 202

Thermomagnetic Applicator – Product Description 202

CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview 203

t-VNS – Dementia – Product Status 203

t-VNS – Dementia – Product Description 203

Cerebain Biotech Corp Pipeline Products & Ongoing Clinical Trials Overview 204

Cerebain Minimally Invasive Implantable Device – Product Status 204

Cerebain Minimally Invasive Implantable Device – Product Description 204

Cerephex Corporation Pipeline Products & Ongoing Clinical Trials Overview 205

NeuroPoint – Product Status 205

NeuroPoint – Product Description 205

Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 206

Neuros – Product Status 206

Neuros – Product Description 206

Neurosonx SR – Home Version – Product Status 207

Neurosonx SR – Home Version – Product Description 207

Pulsed Transdermal Electrical Stimulation Device – Depression – Product Status 207

Pulsed Transdermal Electrical Stimulation Device – Depression – Product Description 208

Pulsed Transdermal Electrical Stimulation Device – Migraine – Product Status 208

Pulsed Transdermal Electrical Stimulation Device – Migraine – Product Description 208

Transdermal Electrical Neurostimulation Device – Product Status 209

Transdermal Electrical Neurostimulation Device – Product Description 209

Charco Neurotech Ltd Pipeline Products & Ongoing Clinical Trials Overview 210

CUE1 – Product Status 210

CUE1 – Product Description 210

Checkpoint Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 211

Checkpoint BEST System – Product Status 211

Checkpoint BEST System – Product Description 211

Checkpoint Surgical Inc – Ongoing Clinical Trials Overview 212

Checkpoint BEST System – Promoting Healing of Nerves through Electrical Stimulation 213

Chordate Medical AB Pipeline Products & Ongoing Clinical Trials Overview 214

KOS System – Product Status 214

KOS System – Product Description 214

Chordate Medical AB – Ongoing Clinical Trials Overview 215

KOS System – A Clinical Investigation of Kinetic Oscillation Stimulation by the Chordate System S101 in the Treatment of Non Allergic Rhinitis 216

KOS System – A Pilot Study to Evaluate the Efficacy of Intranasal K.O.S in the Preventive Treatment of Chronic Migraine on Patients Not Responding to a Treatment With Monoclonal Antibodies Targeting the CGRP Pathway 216

KOS System – Study of Patients with Dry Eyes, Keratoconjunctivitis Sicca, During Treatment with Kinetic Oscillation Stimulation (KOS) 216

Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview 217

Carotid Body Modulation System – Product Status 217

Carotid Body Modulation System – Product Description 217

Cirtec Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 218

Neuro Stimulation Device – Sleep Apnea – Product Status 218

Neuro Stimulation Device – Sleep Apnea – Product Description 218

Neurostimulation Device – Atherosclerosis – Product Status 219

Neurostimulation Device – Atherosclerosis – Product Description 219

Neurostimulation Device – Chronic Pain – Product Status 219

Neurostimulation Device – Chronic Pain – Product Description 220

ClearPoint Medical Pipeline Products & Ongoing Clinical Trials Overview 221

Neuro Navigation Device – OCD – Product Status 221

Neuro Navigation Device – OCD – Product Description 221

ClearPoint Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview 222

Implantable Neural Electrode – Product Status 222

Implantable Neural Electrode – Product Description 222

Neuro Navigation Device – Alzheimer’s Disease – Product Status 223

Neuro Navigation Device – Alzheimer’s Disease – Product Description 223

Neuro Navigation Device – Insomnia – Product Status 223

Neuro Navigation Device – Insomnia – Product Description 224

Neuro Navigation Device – Parkinson’s Disease – Product Status 224

Neuro Navigation Device – Parkinson’s Disease – Product Description 224

Neuro Navigation Device – Severe Depression – Product Status 225

Neuro Navigation Device – Severe Depression – Product Description 225

Neuro Navigation Device – Stroke Rehabilitation – Product Status 225

Neuro Navigation Device – Stroke Rehabilitation – Product Description 226

Cleveland Clinic Pipeline Products & Ongoing Clinical Trials Overview 227

NeuroActive Catheter Stimulation Device – Product Status 227

NeuroActive Catheter Stimulation Device – Product Description 227

Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 228

Crescendo – Product Status 228

Crescendo – Product Description 228

ParkinTune – Product Status 229

ParkinTune – Product Description 229

Clinatec Pipeline Products & Ongoing Clinical Trials Overview 230

Intracranial Deep Brain Stimulation Device – Product Status 230

Intracranial Deep Brain Stimulation Device – Product Description 230

Wimagine – Product Status 231

Wimagine – Product Description 231

CNX Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 232

Neurostimulation Device – Product Status 232

Neurostimulation Device – Product Description 232

Cognito Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 233

GammaSense Stimulation System – Product Status 233

GammaSense Stimulation System – Product Description 233

Cognito Therapeutics Inc – Ongoing Clinical Trials Overview 234

GammaSense Stimulation System – Multi-center Study of Sensory Stimulation to Improve Brain Function: Overture Study 235

GammaSense Stimulation System – Multi-Center Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) 235

GammaSense Stimulation System – Sensory-Evoked Cortical Gamma Oscillation: Impact on Visual Processing and Cognitive Function in Patients with Alzheimer’s Disease 235

Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 236

INTIBIA Implantable Tibial Nerve Stimulator – Product Status 236

INTIBIA Implantable Tibial Nerve Stimulator – Product Description 236

ITNS Implantable Tibial Nerve Stimulator – Product Status 237

ITNS Implantable Tibial Nerve Stimulator – Product Description 237

Coloplast A/S – Ongoing Clinical Trials Overview 238

INTIBIA Implantable Tibial Nerve Stimulator – A Prospective, Randomized Clinical Trial Evaluating INTIBIA, an Investigational Implantable Tibial Nerve Stimulator, Through 24-Months (INTIBIA Pivotal Study IU024) 239

Columbia Engineering Pipeline Products & Ongoing Clinical Trials Overview 240

MTA System – Product Status 240

MTA System – Product Description 240

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 241

Transcranial Magnetic Stimulation Device – Product Status 241

Transcranial Magnetic Stimulation Device – Product Description 241

Comphya SA Pipeline Products & Ongoing Clinical Trials Overview 242

CaverSTIM – Product Status 242

CaverSTIM – Product Description 242

Conservocare, LLC Pipeline Products & Ongoing Clinical Trials Overview 243

Conservocare Bladder Implant – Product Status 243

Conservocare Bladder Implant – Product Description 243

Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 244

Automatic Phrenic Nerve Stimulation System – Product Status 244

Automatic Phrenic Nerve Stimulation System – Product Description 244

Coridea GSN Stimulator – Product Status 245

Coridea GSN Stimulator – Product Description 245

On-Demand Electrostimulation Device – Product Status 245

On-Demand Electrostimulation Device – Product Description 246

Cortec GmbH Pipeline Products & Ongoing Clinical Trials Overview 247

Brain Interchange Implant System – Product Status 247

Brain Interchange Implant System – Product Description 247

Cortec GmbH – Ongoing Clinical Trials Overview 248

Brain Interchange Implant System – Acute Modulation of Stereotyped High-Frequency Oscillations With a Closed-Loop Brain Interchange System in Drug-Resistant Epilepsy 249

Cortivis Pipeline Products & Ongoing Clinical Trials Overview 250

Cortical Visual Neuroprosthesis Implant – Product Status 250

Cortical Visual Neuroprosthesis Implant – Product Description 250

Cortivis – Ongoing Clinical Trials Overview 251

Cortical Visual Neuroprosthesis Implant – Pilot Study for the Development of a Cortical Visual Neuroprosthesis for the Blind Based on Intracortical Microelectrodes 252

Cyberonics Inc Pipeline Products & Ongoing Clinical Trials Overview 253

Nerve Wrap – Product Status 253

Nerve Wrap – Product Description 253

Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 254

TOPS Device – Alzheimer’s disease – Product Status 254

TOPS Device – Alzheimer’s disease – Product Description 254

TOPS Device – Depression – Product Status 255

TOPS Device – Depression – Product Description 255

TOPS Device – Epilepsy – Product Status 255

TOPS Device – Epilepsy – Product Description 256

TOPS Device – Obesity – Product Status 256

TOPS Device – Obesity – Product Description 256

TOPS Device – Obsessive-Compulsive Disorder – Product Status 257

TOPS Device – Obsessive-Compulsive Disorder – Product Description 257

TOPS Device – Parkinson’s disease – Product Status 257

TOPS Device – Parkinson’s disease – Product Description 258

Deep Brain Stimulation Technologies Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 259

ASTUTE System – Product Status 259

ASTUTE System – Product Description 259

DEYMED Diagnostic Pipeline Products & Ongoing Clinical Trials Overview 260

DuoMAG MP – Product Status 260

DuoMAG MP – Product Description 261

DuoMAG XT – Product Status 261

DuoMAG XT – Product Description 262

DEYMED Diagnostic – Ongoing Clinical Trials Overview 263

DuoMAG XT – Probing Language Processes Using Transcranial Magnetic Stimulation 264

Dignify Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 265

Pudendal Neuromodulation Device – Product Status 265

Pudendal Neuromodulation Device – Product Description 265

Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 266

Iowa-Patch System – Product Status 266

Iowa-Patch System – Product Description 266

Drexel University Pipeline Products & Ongoing Clinical Trials Overview 267

Epileptic Seizure Control Device – Product Status 267

Epileptic Seizure Control Device – Product Description 267

Duke University Pipeline Products & Ongoing Clinical Trials Overview 268

DBS Electrode – Product Status 268

DBS Electrode – Product Description 268

Spinal Cord Stimulator – Product Status 269

Spinal Cord Stimulator – Product Description 269

DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview 270

Intraluminal Implantable Device – Product Status 270

Intraluminal Implantable Device – Product Description 270

Dysphagia Pipeline Products & Ongoing Clinical Trials Overview 271

Neurostimulation Device – Dysphagia – Product Status 271

Neurostimulation Device – Dysphagia – Product Description 271

EBS Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 272

Alpha Synch – Aphasia – Product Status 272

Alpha Synch – Aphasia – Product Description 272

Alpha Synch – Vision Impairments – Product Status 273

Alpha Synch – Vision Impairments – Product Description 273

EBT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 274

SaphStim – Product Status 274

SaphStim – Product Description 274

Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 275

OpticSELINE – Product Status 275

OpticSELINE – Product Description 275

Eisana Corp Pipeline Products & Ongoing Clinical Trials Overview 276

Electrical Stimulation Device – Product Status 276

Electrical Stimulation Device – Product Description 276

ElectroCore Inc Pipeline Products & Ongoing Clinical Trials Overview 277

ElectroCore RMS-1100 Resolution Motility System – Post-Operative Ileus – Product Status 277

ElectroCore RMS-1100 Resolution Motility System – Post-Operative Ileus – Product Description 278

GammaCore – Gastroparesis – Product Status 278

GammaCore – Gastroparesis – Product Description 278

GammaCore – Opioid Use Disorder – Product Status 279

GammaCore – Opioid Use Disorder – Product Description 279

GammaCore – Parkinsonian Gait – Product Status 279

GammaCore – Parkinsonian Gait – Product Description 280

GammaCore – Post-Traumatic Headache – Product Status 280

GammaCore – Post-Traumatic Headache – Product Description 280

GammaCore – Post-Traumatic Stress Disorder – Product Status 281

GammaCore – Post-Traumatic Stress Disorder – Product Description 281

Gammacore – Reactive Airway Disease – Product Status 281

Gammacore – Reactive Airway Disease – Product Description 282

GammaCore – Rheumatoid Arthritis – Product Status 282

GammaCore – Rheumatoid Arthritis – Product Description 282

GammaCore – Sjogren’s Syndrome – Product Status 283

GammaCore – Sjogren’s Syndrome – Product Description 283

GammaCore – Stroke – Product Status 283

GammaCore – Stroke – Product Description 284

GammaCore – Subarachnoid Hemorrhage – Product Status 284

GammaCore – Subarachnoid Hemorrhage – Product Description 284

GammaCore – Traumatic Brain Injury – Product Status 285

GammaCore – Traumatic Brain Injury – Product Description 285

GammaCore – Ulcerative Colitis – Product Status 285

GammaCore – Ulcerative Colitis – Product Description 286

Resolve Stimulator And Proximity Electrode – Product Status 286

Resolve Stimulator And Proximity Electrode – Product Description 286

ElectroCore Inc – Ongoing Clinical Trials Overview 287

GammaCore – Gastroparesis – Non-invasive Vagal Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients with Gastroparesis and Related Disorders 288

ElectroCore RMS-1100 Resolution Motility System – Post-Operative Ileus – Transcutaneous Vagal Nerve Stimulation to Reduce Ileus: A Feasibility Study (TRANSIT) 289

GammaCore – Post-Traumatic Stress Disorder – Transcutaneous Cervical Vagal Nerve Stimulation in Patients with Posttraumatic Stress Disorder (PTSD): A Pilot Study of Effects on PTSD Symptoms and Interleukin-6 Response to Stress 290

GammaCore – Post-Traumatic Stress Disorder – Transcutaneous Vagal Nerve Stimulation in Veterans With Posttraumatic Stress Disorder 290

GammaCore – Subarachnoid Hemorrhage – Safety and Efficacy of Non-invasive Vagus Nerve Stimulation in the Treatment of Headache in Subarachnoid Hemorrhage 291

GammaCore – Subarachnoid Hemorrhage – Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage: STORM 291

GammaCore – Opioid Use Disorder – Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders 292

GammaCore – Traumatic Brain Injury – Non-Invasive Vagal Nerve Stimulation in Veterans with Mild Traumatic Brain Injury (mTBI) 293

Elira Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 294

Elira Transcutaneous Electrical Nerve Stimulation Device – Product Status 294

Elira Transcutaneous Electrical Nerve Stimulation Device – Product Description 294

EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 295

PercuStim System – Product Status 295

PercuStim System – Product Description 295

TranStim Transdermal Neuromodulation System – Product Status 296

TranStim Transdermal Neuromodulation System – Product Descrip

Figures

Neuromodulation Devices – Pipeline Products by Stage of Development 60

Neuromodulation Devices – Pipeline Products by Segment 61

Neuromodulation Devices – Pipeline Products by Territory 62

Neuromodulation Devices – Pipeline Products by Regulatory Path 64

Neuromodulation Devices – Pipeline Products by Estimated Approval Date 66

Neuromodulation Devices – Ongoing Clinical Trials 67

Frequently asked questions

Neuromodulation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Neuromodulation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Neuromodulation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update in real time.

  • Access a live Neuromodulation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.